Abstract
Bacterial, fungal, and occasionally protozoal infection continue to be important complications of marrow transplantation. Although bacterial infection as a primary cause of death is rare, such infection may add substantially to the morbidity and cost of transplantation. Moreover, bacterial infection is an important concomitant of both the treatment and outcome of acute graft versus host disease (GVHD). Fungal infection occurs less commonly than bacterial infection, but with a higher case fatality rate. Some fungi such as Aspergill us have emerged as frequent causes of death in individual transplant units [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Peterson PK, McGlave P, Ramsay NKC, Rhame F, Cohen E, Perry GS, Goldman AI, Kersey (1983) A prospective study of infectious diseases following bone marrow transplantation: emergence of aspergillus and cytomegalovirus as the major causes of mortality. Infect Control 4:81–89
Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell CT, Thomas ED and the Seattle Marrow Transplant Team (1978) Protective environment for marrow transplant recipients. A prospective study. Ann Intern Med 89:893–901
Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD (1978) Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 298:1052–1057
Winston DJ, Ho WG, Young LS, Gale RP (1980) Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 68:893–897.
Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE (1986) Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med 80:884–890
Witherspoon RP, Storb, R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, Deeg HJ, Sosa R, Noel DR, Atkinson K, Thomas ED (1981) Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 58:360–368
Winston DJ, Schiffman G, Wang DC, Feig SA, Lin CH, Marso EL, Ho WG, Young LS, Gale RP (1979) Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med 91:835–841.
Buckner CD, Clift RA, Thomas ED, Hersman J, Sanders JE, Stewart PS, Wade JC, Murphy M, Counts G, Meyers JD (1983) Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: Effects of prophylactic measures. Infection 11:243–250
Navari RM, Buckner CD, Clift RA, Storb R, Sanders JE, Stewart P, Sullivan KM, Williams B, Counts GW, Meyers JD, Thomas ED (1984) Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. Am J Med 76:564–572
Petersen FB, Buckner CD, Clift RA, Lee S, Nelson N, Counts GW, Meyers JD, Sanders JE, Stewart PS, Bensinger WI, Navari R, Thomas ED (1986) Laminar air flow isolation and decontamination: A prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients. Infection 14:115–121
Petersen FB, Buckner CD, Clift RA, Nelson N, Counts GW, Meyers JD, Thomas ED (1986) Prevention of nosocomial infections in marrow transplant patients: A prospective randomized comparison of systemic antibiotics versus granulocyte transfusions. Infect Control 7:586–592
Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R (1982) The effect of granulocyte transfusions upon the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 96:149–152
Clark RA, Johnson FL, Klebanoff SJ, Thomas ED (1976) Defective neutrophil Chemotaxis in bone marrow transplant patients. J Clin Invest 58:22–31
Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED (1982) Analysis of late infections after human bone marrow transplantation: Role of genotypic non identity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60:714–720
Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, Meyers JD (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314:1006–1010
Petersen FB, Bowden RA, Thornquist M, Meyers JD, Buckner CD, Counts GW, Nelson MT, Newton BA, Sullivan KM, Mclver J, Thomas ED (1987) The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. Bone Marrow Transplantation, in press
Winston DJ, Ho WG, Lin C-H, Bartoni K, Budinger MD, Gale RB, Champlin R (1987) Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 106:12–18
Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED (1983) Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 302–307
Meyers JD, Thomas ED (1981) Infection complicating bone marrow transplantation. In: Rubin RH, Young LS (ed) Clinical Approach to infection in the immunocompromised host. New York: Plenum Press
Shepp DH, Klosterman A, Siegel MS, Meyers JD (1985) Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in the protective environment. J Infect Dis 152:1257–1263
Winston DJ, Gale RP, Meyer DV, Young LS, and the UCLA Bone Marrow Transplantation Group (1979) Infectious complications of human bone marrow transplantation. Medicine 58:1–31
Shepp DH, Hackman RC, Conley FK, Anderson JB, Meyers JD (1985) Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture. Ann Intern Med 103:218–221
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this paper
Cite this paper
Meyers, J. et al. (1988). Bacterial, Fungal, and Protozoan Infection After Marrow Transplantation. In: Baum, S.J., Santos, G.W., Takaku, F. (eds) Recent Advances and Future Directions in Bone Marrow Transplantation. Experimental Hematology Today—1987, vol 1987. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3762-4_29
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3762-4_29
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8339-3
Online ISBN: 978-1-4612-3762-4
eBook Packages: Springer Book Archive